Predictions
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€70.76
26.10.21
26.10.21
€65.00
26.10.22
26.10.22
38.64%
27.10.22
27.10.22
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€42.04
05.11.21
05.11.21
€70.00
31.12.24
31.12.24
11.00%
02.09.22
02.09.22
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€70.70
05.11.21
05.11.21
€60.00
31.12.23
31.12.23
28.01%
24.08.22
24.08.22
Could be worthwhile Investment >10% per year
Johnson & Johnson
Start price
Target price
Perf. (%)
€142.86
08.07.21
08.07.21
€177.00
08.07.22
08.07.22
22.71%
08.07.22
08.07.22
Pfizer Inc.
Start price
Target price
Perf. (%)
€46.84
04.04.22
04.04.22
€55.00
04.04.23
04.04.23
2.48%
16.04.22
16.04.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€48.26
23.03.22
23.03.22
€55.00
23.03.23
23.03.23
-3.61%
02.04.22
02.04.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€33.21
08.07.21
08.07.21
€55.00
08.07.22
08.07.22
29.12%
18.02.22
18.02.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€41.11
09.11.21
09.11.21
€60.00
09.11.22
09.11.22
14.73%
19.01.22
19.01.22
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Johnson & Johnson
Start price
Target price
Perf. (%)
€147.94
22.12.21
22.12.21
-
22.12.25
22.12.25
1.31%
28.12.21
28.12.21
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Pfizer Inc.
Start price
Target price
Perf. (%)
€31.40
18.11.20
18.11.20
-
18.11.21
18.11.21
45.06%
19.11.21
19.11.21
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Low dividend yield expected
Pfizer Inc.
Start price
Target price
Perf. (%)
€29.35
15.03.21
15.03.21
€50.00
15.03.22
15.03.22
43.43%
09.11.21
09.11.21
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Pfizer Inc.
Start price
Target price
Perf. (%)
€27.04
17.03.20
17.03.20
€33.21
04.11.21
04.11.21
47.75%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Johnson & Johnson
Start price
Target price
Perf. (%)
€117.78
11.03.20
11.03.20
€150.00
04.11.21
04.11.21
20.58%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€83.00
22.12.19
22.12.19
€79.00
04.11.21
04.11.21
-3.61%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€71.50
01.03.19
01.03.19
€77.00
04.11.21
04.11.21
-1.04%
26.10.21
26.10.21
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€39.50
28.08.21
28.08.21
-
28.08.22
28.08.22
0.10%
04.09.21
04.09.21
Risky Investment
Pfizer Inc.
Start price
Target price
Perf. (%)
€31.50
30.11.20
30.11.20
€38.00
30.11.21
30.11.21
18.40%
02.08.21
02.08.21
Could be worthwhile Investment >10% per year
Very high dividend yield expected
Fair valuation
Higher EBIT margin than peer group
Pfizer Inc.
Start price
Target price
Perf. (%)
€33.31
09.07.21
09.07.21
-
09.07.22
09.07.22
0.27%
09.07.21
09.07.21
Top 10 in its market
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€30.93
04.08.20
04.08.20
€38.00
04.11.21
04.11.21
0.31%
13.04.21
13.04.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Johnson & Johnson
Start price
Target price
Perf. (%)
€136.62
24.03.21
24.03.21
€145.00
24.03.22
24.03.22
-1.26%
09.04.21
09.04.21
Known brand
Future proof or reliable business model
Medium risks for its business